title: Letter: anti-CTLA-4-associated colitis and inflammatory bowel disease pathogenesis--authors' reply.
authors.affiliation: Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
authors.forename: A
authors.initials: A
authors.lastname: Gupta
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
authors.forename: K M
authors.initials: KM
authors.lastname: De Felice
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
authors.forename: E V
authors.initials: EV
authors.lastname: Loftus
authors.affiliation: Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX, USA. khanna.sahil@mayo.edu.|Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. khanna.sahil@mayo.edu.
authors.forename: S
authors.initials: S
authors.lastname: Khanna
mesh_terms: D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors*; D003092:Colitis / Q000139:chemically induced*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*
chemical_list: D060908:CTLA-4 Antigen